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See related article on page 521. One of the Holy Grails of pediatric cardiac surgeons is an operationfor coarctation of the aorta that results in no postoperative reco-arctation or hypertension. Five decades have gone by since thefirst coarctation repair by Crafoord in 1944. The results of coarc-tation repair during that time have been steadily improving. Mor-tality is now almost exclusively related to associated cardiac
anomalies. The greatly feared complications of paraplegia and mesenteric ischemia
have been nearly eliminated. Now we are focused on trying to perfect the techniques
of coarctation repair to eliminate recoarctation and minimize postoperative hyper-
tension.
Walhout and colleagues1 have reviewed the outcomes of 262 children undergo-
ing repair of coarctation of the aorta between 1973 and 2000. They compared the
results of patients who had a polytetrafluoroethylene (PTFE) patch aortoplasty
versus those of patients who had resection of the coarctation with an end-to-end
anastomosis (REEA). There was no mortality from isolated coarctation repair. There
were no patients with postoperative paraplegia. The techniques (REEA vs PTFE
patch aortoplasty) did not differ in the incidence of recoarctation. PTFE patch repair
that included coarctation ridge resection was found to be a risk factor for late
aneurysm formation. PTFE patch repair was associated with increased late hyper-
tension compared with results in those patients who had REEA. Arch hypoplasia
and young age (1 month) were found to be risk factors for recoarctation. The
authors recommend REEA when it is anatomically possible because of the favorable
results, especially the lower incidence of late hypertension.
The authors are to be congratulated for their extensive review of one of the
largest series of coarctation repairs reported and carefully followed up over a long
period of time. Their careful analysis gives a slight edge to REEA over PTFE patch
aortoplasty. The main limitations of this review are that it was a nonrandomized
retrospective review, and there is no group of patients undergoing resection with
extended end-to-end anastomosis. Nonrandomization means that the surgeon made
a decision in the operating room as to whether a resection with end-to-end anasto-
mosis was possible or decided perhaps because a resection could not be performed
safely that a patch aortoplasty should be performed. This intraoperative decision,
based on a variety of variables, would tend to stratify the outcome of the patients.
The other limitation of this study is partly historical, but even in the recent
patients in this series, apparently none had resection and extended end-to-end
anastomosis. This has been our procedure of choice at Children’s Memorial Hospital
for infants with coarctation since 1991.2 This procedure includes resection of the
coarctation and an incision in the undersurface of the transverse arch with a mirror
counterincision in the descending thoracic aorta. This leads to a long oblique
anastomosis that crosses potential sites for recoarctation. The technique of resection
with extended end-to-end anastomosis addresses many of the anatomic features that
have been associated with recoarctation. All ductal tissue is resected, the anasto-
mosis augments a hypoplastic transverse aortic arch or isthmus, and the use of
autologous tissue allows for growth of the anastomosis. The operation specifically
addresses arch hypoplasia and young age, 2 risk factors for recoarctation identified
in this study. A meta-analysis reviewing 6 institutions’ incidences of recoarctation
with the technique of resection with extended end-to-end anastomosis revealed a
recoarctation rate of 7% in 507 patients.3 This is less than the recoarctation rate of
21% reported in the current review.
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PTFE patch repair in this series was noted to have a high
incidence of aneurysm formation when the coarctation ridge
was excised, with no aneurysms observed when the coarc-
tation ridge was not excised. Late aneurysms occurred in 8
patients in this series when the coarctation ridge was ex-
cised and in no patient when ridge resection was not per-
formed. This outcome is similar to the findings in our
review of the PTFE patch aortoplasty, in which we noted no
true aneurysm formation in over 125 patients undergoing
PTFE patch aortoplasty (none of our patients had coarcta-
tion ridge resection).4 This I believe to be an important
finding because it helps confirm the safety of PTFE patch
aortoplasty. It also emphasizes that resection of the coarc-
tation ridge should not be performed when a patient is
undergoing PTFE patch aortoplasty.
The authors of the current study1 found that the PTFE
patch repair had a higher incidence of late hypertension than
REEA. Late hypertension (defined as blood pressure
150/90 mm Hg in the right arm) occurred in 3 patients
undergoing REEA and 8 patients undergoing PTFE patch
aortoplasty. We found a high incidence of recoarctation
(and hence hypertension) in our PTFE patch aortoplasty
series if the patch technique was used in patients less than 1
month of age.4 In our series, if the patch repair was per-
formed at less than 1 month of age, recoarctation occurred
in 6 of 12 patients. That is part of what prompted us to
abandon the PTFE patch aortoplasty in favor of resection
with extended end-to-end anastomosis for infants with co-
arctation of the aorta.
The following question arises: In which patients should a
PTFE patch aortoplasty technique be used? One particular
subgroup identified in this series that I believe is of concern
are those patients who had an attempted resection with
end-to-end anastomosis that was then converted to a PTFE
patch aortoplasty. I believe the occurrence of that intraop-
erative complication should be avoided whenever possible,
and those patients should probably have had a primary
PTFE patch aortoplasty. Patients who have a primary repair
with one crossclamp application followed by a second
crossclamp application shortly afterward during the same
procedure to address the continuing coarctation are at in-
creased risk for paraplegia.3 Before performing a resection
and end-to-end anastomosis, the surgeon should take all
possible precautions to ensure that the 2 ends will be able to
come together. This might require extensive mobilization of
the descending thoracic aorta, including ligating and divid-
ing multiple sets of collateral vessels and full mobilization
of the transverse aortic arch, including the left subclavian
artery, the left carotid artery, and the innominate artery, with
division of their pericardial attachments. Another group of
patients for whom PTFE patch aortoplasty might be the
technique of choice are those with extensive collaterals who
are at risk of intraoperative hemorrhage. These collaterals
can be very large, tortuous, and fragile. Attempts to ligate
and divide them in an effort to mobilize the aorta might lead
to catastrophic hemorrhage. Obversely, the older child (1
to 2 years of age) who has very few collaterals is also well
suited to a PTFE patch repair. These patients without col-
lateral formation are at risk for paraplegia if the aortic clamp
time is prolonged. One advantage of the patch aortoplasty
technique is the relatively short aortic clamp time (mean of
26 minutes in our series). A fourth indication for PTFE
patch aortoplasty is a reoperation after previous repair (most
commonly REEA). In the series of Walhout and col-
leagues,1 18 of the patients who had a reoperation had a
PTFE patch aortoplasty versus only 2 undergoing a repeat
REEA. In our review PTFE patch aortoplasty was the most
common technique used for a recoarctation repair.3 Finally,
PTFE patch aortoplasty is indicated for older patients with
arch hypoplasia in whom the patch is brought up into the
transverse arch either through a left thoracotomy or from a
median sternotomy approach. We are currently not using
PTFE patch aortoplasty in infants less than 1 year of age or
for patients greater than 18 years of age. In the younger age
group, as mentioned earlier, we demonstrated a high inci-
dence of recoarctation. In the older age group we avoid this
technique because of the prolonged abnormal physiology
resulting in poststenotic dilatation and thinning of the de-
scending thoracic aorta that puts the patient at increased risk
for aneurysm formation. Adult patients with coarctation
should have a resection of the coarctation with placement of
an interposition graft.
The timing of the operation with regard to the risk of
recoarctation in this review was an interesting and very
relevant finding. Age at operation of less than 1 month was
a risk factor for recoarctation. Of course, many of the
patients less than 1 month of age are receiving alprostadil
(prostaglandin E1), and repair cannot be delayed. However,
there was no difference in the incidence of late recoarctation
in patients operated on from 1 month of age to 1 year of age
compared with patients greater than 1 year of age. There
was no benefit to waiting for patients over 1 month of age
to be older to decrease the risk of recoarctation. This cor-
responds with our philosophy that coarctation should be
repaired at the time of diagnosis.
We might be at a point at which it is not technical-
surgical advances but rather modulation of the healing pro-
cess that will lead to the desired Holy Grail of no recoarc-
tation and no late hypertension. To this end, we have been
studying the effect of vascular endothelial growth factor on
the healing of a vascular anastomosis in a coarctation mod-
el.5 We found that the topical application of vascular endo-
thelial growth factor to the anastomotic site results in en-
hanced healing with less fibrosis, less cellular infiltrate, and
no focal dystrophic medial calcification.
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What does the review by Walhout and colleagues1 tell
us? First, when possible, REEA might be superior to PTFE
patch aortoplasty, with a slightly lower incidence of reco-
arctation and a significantly lower incidence of late hyper-
tension. However, these conclusions must be tempered
given the fact that this was not a randomized prospective
study. Second, the incidence of aneurysm formation after
PTFE patch aortoplasty is very low when the coarctation
ridge is not resected. Third, patch aortoplasty is an effective
bail-out procedure when resection with end-to-end anasto-
mosis fails in the operating room. Finally, both arch hyp-
oplasia and age of less than 1 month are independent risk
factors for recoarctation.
I believe infants with coarctation of the aorta should be
treated with resection and extended end-to-end anastomosis,
and older children (1-2 years of age) can be treated with
either resection and extended end-to-end anastomosis (if
technically feasible) or with PTFE patch aortoplasty. Adults
with coarctation should have an interposition graft. We as
surgeons must strive to analyze our results by using differ-
ent surgical techniques and attempt to use this information
to generate the optimum outcome for patients with coarc-
tation of the aorta. It might take more research at an endo-
thelial cell–molecular level to fully achieve this Holy Grail
of no recoarctation and no residual hypertension.
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